Pevonedistat (MLN4924), an inhibitor of the Nedd8 activating enzyme, has also been shown to synergize with venetoclax in AML cell lines and in fresh AML patients' cells, through neutralization of MCL-1 and activation of the pro-apoptotic proteins Bax and Bak (42). This evidence concerns the gene BAX and acute myeloid leukemia.